Jan 25,2022

Medication adherence doubles when patients use digital health apps

In a study recently published in Nature’s Scientific Reports, Propeller Health found that controller medication adherence among patients with chronic respiratory disease was more likely to increase (up to twofold) with digital health app engagement. Data was collected from a study group that included 1,629 participants with asthma and 663 participants with COPD who were using the Propeller platform.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Feb 24,2022

The majority of patients find remote care helpful. Clinicians can benefit from p…

More and more patients with chronic conditions like asthma have adopted remote care and digital health tools to self-manage their conditions since the start of the COVID-19 pandemic. Survey results from a recent Propeller Health study to be presented at the 2022 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting found that the majority of patients (68.7%) find their use of remote care helpful. Of the 441 patients surveyed, about one third of patients reported that they connected with their asthma providers through video visits and messaging services.

PRODUCT

#connected device

#virtual care

View Analyst & Ambassador Comments
Go to original news
Feb 28,2022

Reducing dose frequency may help improve asthma medication adherence

Findings from a Propeller Health study recently published in The Journal of Allergy and Clinical Immunology demonstrated that patients with asthma who are prescribed once-daily dosing schedules are more likely to adhere to their controller medications than those with twice-daily prescriptions. The percentage of patients who achieved greater than 80% adherence was also significantly higher for once-daily users compared to twice-daily users, with once-daily users being 1.4 times as likely to achieve high medication adherence as twice-daily users.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Mar 07,2022

Propeller Health accelerates access to digital health solutions

ResMed subsidiary Propeller Health on Monday unveiled at the ViVE conference new solutions and updates that it says will expand access to its FDA-cleared digital platform. Specifically, the company introduced a new respiratory care solution to enable remote therapeutic monitoring (RTM) by healthcare providers, integrated its platform with multiple electronic health record (EHR) systems and updated its digital platform to enable respiratory care at "home, in-clinic and on-the-go."

PRODUCT

#rpm

View Analyst & Ambassador Comments
Go to original news
Apr 06,2022

New Propeller Health data on patient behavior to be revealed at SBM 2022

Research continues to show how positive behavior change can play an important role in improving health outcomes, especially among patients with chronic conditions such as asthma and COPD. With three peer-reviewed abstracts accepted for presentation at the Society of Behavioral Medicine (SBM) 2022 Annual Meeting on April 6-9, Propeller Health’s recent findings on patient behavior – as they relate to the pandemic, digital health use and smoking prevalence – add to this growing body of knowledge.

CLINICAL STUDY

#mobile app

#connected device

View Analyst & Ambassador Comments
Go to original news
Apr 11,2022

Symptom-related disruptions and rescue inhaler use decreases among Propeller users with asthma

In a recent Propeller Health study, the company observed that patients (n=1,679) with asthma who used a digital health platform had significant improvements in rescue inhaler use and self-reported activity rates over three months. Data was captured using Propeller’s digital health platform, which includes an inhaler sensor that passively collects medication use data and a mobile app that engages patients in chronic condition self-management.

CLINICAL STUDY

#connected device

#mobile app

View Analyst & Ambassador Comments
Go to original news
May 25,2022

NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment

NuvoAir is collaborating with 17 NHS trusts to launch a virtual Asthma Assessment Service designed to increase clinical capacity, reduce time to diagnosis, and provide ongoing remote patient monitoring and management. NuvoAir’s Asthma Assessment Service uses respiratory physiologists and connected technology, such as the Air Next spirometer to assess lung function variability, and the Aos pMDI sensor to track inhaler usage and technique. Respiratory patients follow their data in the NuvoAir Home app while healthcare teams access assessment reports, gain longitudinal insights, and efficiently address care needs.

PRODUCT

#connected device

#virtual care

#rpm

View Analyst & Ambassador Comments
Go to original news
Sep 08,2022

Breaking Respiratory Research Findings From Propeller Health Unveiled at ERS 2022

Propeller Health and its research partners presented five abstracts at this year’s European Respiratory Society (ERS) International Congress. Our latest research explored the relationship between respiratory comorbidities and healthcare utilization, the effect of digital health solutions on medication adherence and asthma control, and projected prevalence of COPD by the year 2050.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Aug 13,2021

my mhealth has announced the first international rollout of its NHS-approved COPD app myCOPD in New Zealand

UK-based digital therapeutics company, my mhealth has announced the first international rollout of its NHS-approved COPD app, myCOPD in New Zealand. The rollout is initially focused on the Māori and Pasifika population, making it the first NHS approved digital self-management programme for COPD to be available in a clinical setting beyond British borders.

PRODUCT

#mobile app

#rpm

View Analyst & Ambassador Comments
Go to original news
Apr 09,2021

New research shows Propeller improves outcomes for patients with high burden of COPD

At Propeller, we want to make this information accessible to patients and their clinicians so they can make informed decisions and understand long-term trends in the patient’s condition. To do so, we prompt patients with COPD to take the CAT once a month in the Propeller app and share the results with patients and their providers. By combining CAT scores and the objective medication usage data Propeller collects, we can better understand the patient’s COPD status and the need for further intervention. In a new article published in Frontiers in Digital Health, we observed significant, parallel improvements in CAT scores and rescue inhaler use among 611 patients with COPD using the Propeller platform.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Subscribe to RESPIRATORY